Objectives: A total aim of this study was to assess the incidence of urinary incontinence in patients following radical prostatectomy and determine the factors that may influence this incidence.Methods: A total of 135 men underwent radical retropubic prostatectomy at our center between 1987 and 1997. 120 patients were sent a questionnaire regarding preoperative and postoperative voiding habits. Data collected included preoperative and postoperative continence status, interval to postoperative continence status, associated urinary symptoms, willingness to undergo radical prostatectomy again if need be and additional postoperative procedures. Patient age, date of surgery, number of neurovascular bundles resected at prostatectomy and duration of follow–up were also noted.Results: Of the 120 patients, 116 (96.7%), a mean of 65.2 (range 48–76) years old, responded to the questionnaire. Mean follow–up was 4.3 years (range 1–10.8). Continence was defined as no regular use of pads. Our overall urinary incontinence rate was 14.4%. Of the respondents, 88.8% (103/116) had achieved final continence status by 6 months postoperatively, and 95% (110/116) would undergo surgery again if need be. Of the patients considered incontinent postoperatively, 66.6% had associated urgency. Age, year of surgery, number of neurovascular bundles resected at prostatectomy, preoperative urinary leakage of postvoiding dribbling, postoperative pelvic floor exercises, and anastomotic stricture had no significant impact on postoperative continence status.Conclusions: Using an anonymous self–administered questionnaire, we found a 14.4% incontinence rate after radical prostatectomy. These results allow patients to have realistic expectations when counseled prior to this operation.

Keywords:
Prostatic neoplasms, Prostatectomy, Urinary incontinence
1.
Lu–Yao GL, McLerran D, Wasson J: An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. JAMA 1993;269:2633–2639.
2.
Fowler FJ, Barry MJ, Lu–Yao G, Wasson J, Roman A, Weinberg J: Effect of radical prostatectomy for postate cancer on patient quality of life: Results from a Medicare survey. Urology 1995;45:1007–1015.
3.
Catalona WJ, Basler JW: Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993;150:905–907.
4.
Steiner MS, Morton RA, Wash PC: Impact of anatomical radical prostatectomy on urinary continence. J Urol 1991;145:512–515.
5.
Leandri P, Rossignol G, Gautier JR, Ramon J: Radical retropubic prostatectomy: Morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992;147:883–886.
6.
Eastham JA, Kattan MW, Rogers E, Goad JR, Ohori M, Boone TB, Scardino PT: Risk factors for urinary incontinence after radical prostatectomy. J Urol 1996;156:1707–1713.
7.
Hautmann RE, Sauter TW, Wenderoth UK: Radical retropubic prostatectomy: Morbidity and urinary continence in 418 consecutive cases. Urology 1994;43:47–52.
8.
Davidson PJT, van den Ouden D, Schroeder FH: Radical prostatectomy: Prospective assessment of mortality and morbidity. Eur Urol 1996;29:168–173.
9.
McHorney CA, Koinski M, Ware JE: Comparison of the costs and quality of norms for the SF–36 health survey collected by mail versus telephone interview: Results from a national survey. Med Care 1994;32:551–555.
10.
van Cangh PJ, Richard F, Lorge F, Castille Y, Moxhon A, Opsomer R, De Visscher L, Wese FX, Scaillet P: Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: Results of a prospective randomized study. J Urol 1998;159:164–166.
11.
Jonler M, Messing EM, Rhodes PR, Burskewitz RC: Sequelae of radical prostatectomy. Br J Urol 1994;74:352–358.
12.
Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW: Patientreported symptoms after primary therapy for early prostate cancer: Result of a prospective cohort study. J Clin Oncol 1998;16:275–283.
13.
Donnellan SM, Duncan HJ, McGregor RJ, Russel JM: Prospective assessment of incontinence after radical retropubic prostatectomy: Objective and subjective analysis. Urology 1997;49:225–230.
14.
Jonler M, Madsen FA, Rhodes PR, Sall M, Messing EM, Bruskewitz RC: A prospective study of quantification of urinary incontinence and quality of life in patients undergoing radical retropubic prostatectomy. Urology 1996; 48:433–440.
15.
Goluboff ET, Saidi JA, Mazer S, Bagiella E, Heitjan DF, Benson MC, Olsson C: Urinary continence after radical prostatectomy: The Columbia experience. J Urol 1996;159:1276– 1280.
16.
Herr HW: Quality of life of incontinent men after radical prostatectomy. J Urol 1994;151: 652–654.
17.
Bates TS, Wright MPJ, Gillatt DA: Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS–male questionnaire. Eur Urol 1998;33:165–169.
18.
Fowler FJ, Barry MJ, Lu–Yao G, Wasson J, Roman A, Weinberg J: Patient–reported complications and follow–up treatment after radical prostatectomy. Urology 1993;42:622–629.
19.
Goluboff ET, Chang DT, Olsson CA, Kaplan SA: Urodynamics and the etiology of post–prostatectomy urinary incontinence: The initial Columbia experience. J Urol 1995,153:1034– 1037.
20.
Kaye KW, Creed KE, Wilson GJ, D’Antuno M, Dawkins HJS: Urinary continence after radical retropubic prostatectomy. Analysis and synthesis of contributing factors: A unified concept. Br J Urol 1997;80:445–451.
21.
Haab F, Yamagauchi R, Leach GE: Postprostatectomy incontinence. Urol Clin North Am 1996;23:447–457.
22.
Hammerer P, Huland H: Urodynamic evaluation of changes in urinary control after radical retropubic prostatectomy. J Urol 1997;157: 233–236.
23.
Hollabaugh RS, Dmochowski RR, Kneib TG, Steiner MS: Presevation of putative continence nerves during radical retropubic prostatectomy leads to more rapid return of urinary continence. Urology 1998;51:960–967.
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.